Unverified record. The outcome below was inferred from the share-price reaction around this date. Nobody has confirmed it against an FDA, SEC or company document, and it may be wrong: we have published at least one inferred outcome that turned out to be impossible (see corrections). Treat it as a price observation, not as a regulatory fact. Verified decisions on this site always link a primary source.
Daily close, T-120 (10/9/24) through T+5. Run-up high $39.16 on 3/10/25, low $25.39 on 10/16/24 (T-120 to T-1). FDA decision 3/26/25. Historical price action, not a forecast.
Decision facts
FDA decision date2025-03-26
OutcomeUnconfirmed · price consistent with approval~ price-only (validating)
Decision-day move-1.9%
T-120 run-up (low→high)+10.0% ($32.38→$39.16)
ValidationOutcome consistent with price; primary-source verification in progress.
Market-cap tierMid
Cohort decision-day move (history)2.2% median (n=229)
Cohort move is the historical median absolute decision-day move for this market-cap tier across our run-up study. History, not a prediction.